PD-1/PD-L1 inhibitor 2 (Synonyms: BMS202) |
| Katalog-Nr.GC16762 |
PD-1/PD-L1-Inhibitor 2 ist ein potenter und nicht-peptidischer PD-1/PD-L1-Komplex-Inhibitor mit einem IC50 von 18 nM und einer KD von 8 μM. PD-1/PD-L1-Inhibitor 2 bindet an PD-L1 und blockiert die Interaktion mit menschlichem PD-1/PD-L1. PD-1/PD-L1-Inhibitor 2 hat AntitumoraktivitÄt.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1675203-84-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
BMS-202 is a potent PD-1/PD-L1 inhibitor, which binds to PD-1 and inhibits human PD-1/PD-L1 interaction, with an IC50 of 18 nM[1].
References:
[1]. Zak KM, et al. Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1). Oncotarget. 2016 May 24;7(21):30323-35.
Average Rating: 5 (Based on Reviews and 6 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *